CLINICAL_TRIALS
ClinicalTrials.gov record update
Phase I Study of Carfilzomib for the Treatment of T-Cell Lymphoma
This page presents selected fields from the linked source record. It does not add a medical interpretation.
Record identity and dates
- Source
- ClinicalTrials.gov
- Source record ID
- NCT01336920
- Title field or adapter rule
- protocolSection.identificationModule.officialTitle
- Ingested At
- 2026-04-28T10:39:34.745931+00:00
- Published At
- 2023-09-15T00:00:00+00:00
- Record Updated At
- 2023-09-15
- Timestamp Basis
- source retrieval time was not retained by the feed adapter
- Date limitation
- source retrieval time was not retained by the feed adapter
Fields recorded by this source
- protocolSection.conditionsModule.conditions
["Adult Nasal Type Extranodal NK/T-cell Lymphoma", "Anaplastic Large Cell Lymphoma", "Angioimmunoblastic T-cell Lymphoma", "Peripheral T-cell Lymphoma", "Recurrent Adult T-cell Leukemia/Lymphoma"]- protocolSection.statusModule.lastUpdatePostDateStruct.date
"2023-09-15"- protocolSection.identificationModule.nctId
"NCT01336920"- protocolSection.identificationModule.officialTitle
"Phase I Study of Carfilzomib for the Treatment of T-Cell Lymphoma"- protocolSection.statusModule.overallStatus
"COMPLETED"- protocolSection.designModule.phases
["PHASE1"]- protocolSection.statusModule.resultsFirstPostDateStruct.date
""
Study condition terms
Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.
This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.